Eldorado Gold (NYSE:EGO) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.13 by 7.69 percent. This is a 57.58 percent decrease over earnings of $0.33 per share from the same period last year.
ChromaDex Reports Jury In California Found Elysium Health Breached Its Contract With ChromaDex; Elysium, Mark Morris Will Pay Co. ~$2.25M-$2.5M In Damages, Estimated Interest
Elysium Health to pay ChromaDex approximately $2.25 to $2.50 million in damages plus interest for breach of contract
New partnership with Sinopharm Xingsha and recent partnerships with Walmart, H&H Group, and Ro to
